Rolipram versus imipramine in inpatients with major, “minor” or atypical depressive disorder: A double-blind double-dummy study aimed at testing a novel therapeutic approach

International Clinical Psychopharmacology

Volumn 3, Issue 3, 1988, Pages 245-253

  Bertolino, A ^a   Crippa, D ^d   Didio, S ^b   Fichte, K ^c   Musmeci, G ^b   Porro, V ^a   Rapisarda, V ^b   Sastre Y Hernandez, M ^c   Schratzer, M ^c  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c BAYER PHARMA AG   (Germany)

^d Schering Plough   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 PYRROLIDONE DERIVATIVE; ANTIDEPRESSANT AGENT; IMIPRAMINE; ROLIPRAM;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; HOSPITALIZATION; HUMAN; MALE; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RATING SCALE;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; COMPARATIVE STUDY; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; HOSPITALIZATION; HUMAN; IMIPRAMINE; MALE; MIDDLE AGE; PSYCHIATRIC STATUS RATING SCALES; PYRROLIDINONES; ROLIPRAM;

EID: 0024045691     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/00004850-198807000-00006     Document Type: Article

References (13)

1. Baumann, P. A. and Maitre, L. (1977). Blockade of presynaptic receptors and of amine uptake in the rat brain by the antidepressant mianserin. Naunyn-Schmiedeberg’s Archives of Pharmacology 300, 31-37.
2. Coppen, A. (1967). The biochemistry of affective disorders. British Journal of Psychiatry, 113, 1237-1264.
3. Horn, A. S., Coyle, J. T. and Snyder, S. H. (1971). Catecholamine uptake by synaptosomes from rat brain. Structure activity relationship of drugs with differential effects on dopamine and norepinephrine neurons. Molecular Pharmacology, 7, 66-80.
4. Horowski, R. and Sastre-y-Hemandez, M. (1985). Clinical effects of the neurotropic selective cAMP phosphodiesterase inhibitor rolipram in depressed patients: Global evaluation of the preliminary reports. Current Therapeutic Research, 38, 23-29.
5. Kehr, W., Debus, G. and Neumeister, R. (1985). Effects of rolipram, a novel antidepressant, on monoamine metabolism in rat brain. Journal of Neural Transmission, 63, 1-12.
6. Lapin, I. P. and Oxenkrug, G. F. (1969). Intensification of central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet, i, 132-136.
7. Morgenroth, V. H., Hegstrand, L. R., Roth, R. H. and Greengard, P. (1975). Evidence for involvement of proteinkinase in the activation by adenosine 3’, 5’-monophosphate of brain tyrosine 3-monooxygenase. Journal of Biological Chemistry, 250, 1946-1948.
8. Przegalinski, E. and Bigajska, K. (1983). Antidepressant properties of some phosphodiesterase inhibitors. Polish Journal of Pharmacology and Pharmacy, 35, 233-240.
9. Schildkraut, J. J. (1965). The catecholamine hypothesis of affective disorders: A review of supporting evidence. American Journal of Psychiatry, 122, 509-522.
10. Wachtel, H. (1982). Selective cyclic adenosine 3’, 5’-monophosphate phosphodiesterase inhibitors—a novel class of antidepressants? Abstract 13th C.l.N.P. Congress, Jerusalem, p. 740.
11. Wachtel, H. (1983). Potential antidepressant activity of rolipram and other selective cyclic adenosine 3’, 5’-monophosphate phosphodiesterase inhibitors. Neuropharmacology, 22, 367-372.
12. Wachtel, H. and Schneider, H. H. (1986). Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors. Neuropharmacology, 25, 1119-1126.
13. Zeller, E., Stief, H.-J., Pflug, B. and Sastre-y-Hernandez, M. (1984). Results of a phase II study of the antidepressant effect of rolipram. Pharmacopsychiatry, 17, 188-190.